📅 Date: Monday, June 16, 2025
🕛 Time: 12:00 PM – 1:00 PM Eastern Time
📍 Location: Virtual Seminar @ https://global.gotomeeting.com/join/271724949
🧪 OSD Overview
Join us for an engaging 1-hour discussion featuring:
Dr. Gabriela Hernandez Hoyos (BMS) and Dr. Ilayaraja Muthuramu (J&J)
Experts in genomic risk analysis and safety assessments of CAR T platforms
They will explore:
● Genomic risks in lentiviral vs. gene-edited CAR T products
● Key molecular and functional assays used in risk assessment
● Preclinical safety challenges in autologous vs. allogeneic approaches
● Insights from published case studies and FDA-approved testing strategies
🧠 Who Should Attend?
Scientists, researchers, and professionals working in:
- Gene and cell therapy
- Regulatory science
- Oncology R&D
- Translational medicine
🔗 Why Attend?
- Hear from leaders in the field
- Participate in an open discussion on safety assessment strategies
- Gain insights into regulatory and translational approaches for CAR T therapies
More